Trending Now

Legal Funding Journal is dedicated to informing and engaging the global legal funding community through daily news, insight, analysis and original content.

Latest News

View All

U.S. Treasury Blocks Venezuela from Funding Maduro’s Legal Defense in Drug Trafficking Case

By John Freund |

The question of who pays for Nicolas Maduro's legal representation has become a flashpoint in his federal drug trafficking prosecution, after the U.S. government reversed course on allowing Venezuela to fund his defense.

As reported by Yahoo News, the Treasury Department initially granted a sanctions exception on January 9 permitting the Venezuelan government to cover Maduro's legal expenses, only to revoke the authorization hours later without explanation. Defense attorney Barry Pollack — who previously represented WikiLeaks founder Julian Assange — argued that Venezuelan law and custom require the government to pay the expenses of the president and first lady, and that Maduro cannot otherwise afford counsel.

Maduro and his wife, Cilia Flores, were captured by U.S. special forces during a nighttime raid in Caracas on January 3, 2026. Both pleaded not guilty on January 5 to charges including drug trafficking, narco-terrorism, conspiracy, and money laundering. Prosecutors allege Maduro exploited his 13-year presidency to assist drug traffickers.

Judge Alvin Hellerstein, presiding over the case in the Southern District of New York, is now weighing the funding dispute. Flores may still be eligible to receive government-funded legal representation. Delcy Rodriguez currently leads the Venezuelan government following Maduro's capture.

The case raises broader questions about the intersection of international sanctions, sovereign immunity, and the funding of legal defense in high-profile prosecutions with geopolitical dimensions.

Burford Capital Reports 39 Percent Surge in New Business Commitments for 2025 Amid Earnings Shortfall

By John Freund |

The world's largest litigation finance firm posted a mixed set of results for 2025, pairing record new business activity with near-term earnings that fell short of market expectations.

As reported by PR Newswire, Burford Capital announced that new definitive commitments rose 39 percent year-over-year in 2025, while portfolio modeled realizations grew by $700 million to reach $5.2 billion at year-end. The firm also declared a final dividend of $0.0625 per ordinary share, payable June 12, 2026.

However, fourth-quarter earnings disappointed investors. Extended case durations and unrealized fair value adjustments weighed on results, including a $22 million fair value reduction tied to the Sysco proteins antitrust litigation portfolio.

CEO Christopher Bogart characterized the year as one of strong forward momentum despite the near-term volatility. "We had a terrific 2025 for new business," Bogart said. "The quality of the portfolio remains high, and we believe the future is bright in terms of growing the business and the potential for asymmetric upside value for shareholders."

Analysts project Burford will return to profitability in the first quarter of 2026, with estimated earnings per share of $0.29 on approximately $171 million in revenue. The results underscore a persistent tension in litigation finance: the long duration of legal proceedings can produce lumpy, unpredictable earnings even as the underlying business pipeline expands.

Pravati Capital Partners with SEI to Bring Litigation Finance to Registered Investment Advisors

By John Freund |

One of the oldest litigation finance firms in the United States has announced a strategic partnership aimed at expanding mainstream investor access to the asset class.

As reported by Business Wire via Yahoo Finance, Scottsdale-based Pravati Capital has partnered with financial services firm SEI to provide registered investment advisors with structured access to litigation finance as an alternative investment option. The collaboration will leverage SEI's distribution platform to make litigation funding opportunities available within advisor portfolios.

The partnership reflects growing institutional interest in litigation finance as an alternative asset class. Historically, litigation funding has been difficult for mainstream financial advisors to access on behalf of their clients, with the market largely dominated by specialized funds and institutional investors. The Pravati-SEI arrangement seeks to bridge that gap by creating a more accessible pathway for advisors seeking diversification through non-correlated investments.

The announcement underscores a broader industry shift as litigation finance continues to move from a niche strategy toward greater acceptance within traditional wealth management channels. As the global litigation funding market grows — projected to reach over $25 billion in 2026 — partnerships like this one may signal a new phase of institutional adoption.

UK Litigation Funding Expert Calls for Mandatory Legal Expenses Insurance in Testimony to MPs

By John Freund |

A leading UK litigation funding expert has urged Parliament to consider making legal expenses insurance compulsory for all citizens as a means of improving access to justice.

As reported by Legal Futures, Dr. John Sorabji — co-chair of the Civil Justice Council working party on litigation funding and former principal legal adviser to the Lord Chief Justice — told the Justice Select Committee that mandatory LEI coverage deserves serious consideration. He acknowledged the recommendation is a personal view rather than an official CJC position.

Currently, LEI take-up in England stands at just 8 percent and 13 percent in Wales, compared to 95 percent in Sweden and 35 percent in Germany. Justice Select Committee chair Andy Slaughter suggested public reluctance may stem from a perception that LEI is "a rip-off."

Dr. Sorabji also urged the government to introduce retrospective legislation reversing the Supreme Court's PACCAR judgment, which classified litigation funding arrangements as damages-based agreements — a ruling that has significantly disrupted the UK funding market. The testimony comes as Parliament continues to examine structural barriers to civil justice and the role that both insurance and litigation funding play in enabling access to the courts.

Illinois Lawmaker Introduces Bill to Regulate Third-Party Litigation Funding

By John Freund |

An Illinois state legislator has introduced new legislation aimed at bringing transparency and consumer protections to the state's growing third-party litigation funding market.

As reported by AOL, State Rep. Dan Ugaste, R-Geneva, filed HB5244, which would require disclosure of third-party lawsuit funders, block foreign interests from financing domestic litigation, prevent funders from steering cases or pressuring settlements, and cap investor returns to ensure plaintiffs receive the majority of recoveries.

"If you are going to profit from lawsuits filed in Illinois, you shouldn't be allowed to hide in the shadows," Ugaste said. The bill, he added, "creates basic rules to ensure outside funders aren't steering cases."

Katie Reilly, Executive Director of the Illinois Coalition for Legal Reform, noted that "commercial third-party litigation funding has grown quickly, but Illinois law has not kept pace." The organization expressed support for the measure.

Similar legislation has already passed in Wisconsin and Indiana. However, HB5244 faces uncertain prospects in the Democrat-dominated Illinois General Assembly, where trial lawyers who benefit from third-party financing have historically donated millions to state Democrats. The bill reflects a broader national trend of state-level efforts to impose guardrails on the rapidly expanding litigation funding industry.

LITFINCON Asia to Make Inaugural Debut in Singapore, Signaling Growth of Asia-Pacific Litigation Finance Market

By John Freund |

The litigation finance industry is expanding its global footprint with the announcement of LITFINCON Asia, a new conference set to bring together key players in legal finance for the first time in the Asia-Pacific region.

As reported by PR Newswire, the event will take place on June 4, 2026 at Marina Bay Sands in Singapore. Produced by Siltstone Capital, the conference is designed to convene institutional investors, law firm leaders, corporate counsel, insurance professionals, and legal finance innovators across the region.

"Asia represents one of the fastest-growing and most dynamic markets for litigation finance globally," said Jim Batson, Chief Investment Officer of Legal Finance and Managing Partner at Siltstone Capital.

Programming will feature senior-level panels and discussions covering topics including evolving regulatory frameworks, portfolio and structured finance solutions, cross-border judgment enforcement, mass claims, intellectual property disputes, international arbitration funding, and insurance-backed risk transfer structures.

The launch of a dedicated Asia-Pacific conference reflects the broader institutionalization of litigation finance beyond its traditional strongholds in the United States and Europe. As cross-border disputes and commercial arbitration activity continue to grow across the region, the event aims to serve as a forum for capital deployment discussions and strategic partnerships at the highest levels of the industry.

Deloitte and Grant Thornton Sued in France Over Atos Accounts in Funded Shareholder Claim

By John Freund |

In what is being described as an unprecedented action in French corporate law, nearly 800 shareholders have filed a civil liability claim against Deloitte & Associes and Grant Thornton, the former statutory auditors of Atos, the once-prominent French IT services company and former CAC 40 constituent.

As reported by Atos Audit Action, the claim targets the auditors for allegedly certifying consolidated financial statements that did not reflect the true financial and asset position of the Atos group across six consecutive fiscal years. Shareholders who purchased Atos shares between February 2018 and March 2024 are eligible to participate. The case has been filed with the Nanterre Commercial Court.

The plaintiffs, represented by law firm Vermeille & Co and supported by the Union for the Protection of Shareholders (UPRA), accuse the auditors of approving accounts containing overvalued assets, overly optimistic revenue recognition, and insufficiently provisioned risks. They further allege that the auditors failed to issue going concern warnings despite the company's deteriorating finances, which they argue had been compromised since the early 2020s. Atos shares collapsed from approximately 70 euros in April 2021 to under one euro by April 2024.

The litigation is backed by an unnamed litigation fund that covers all procedural costs in exchange for a commission on any recovery. The case marks the first time in France that a civil liability action has been brought directly against the auditors of a listed company, potentially setting a precedent for future shareholder claims in the French market.

Which? Drops £480 Million Funded Class Action Against Qualcomm

By John Freund |

A £480 million collective proceedings claim against chipmaker Qualcomm has been withdrawn in full after the UK consumer group Which? reassessed its position following trial evidence. The settlement, which requires Competition Appeal Tribunal approval, involves no payment from Qualcomm.

As reported by Non-Billable, the litigation-funded claim was originally filed in 2021 under the UK's collective proceedings framework. Backed by litigation funder Augusta Ventures, Which? alleged that Qualcomm's overcharging at the manufacturer level inflated retail mobile phone prices for millions of consumers. Quinn Emanuel and Norton Rose Fulbright represented Qualcomm in the defense.

According to Quinn Emanuel's statement, the class representative concluded that the tribunal would reject allegations that Qualcomm coerced Apple, chipset manufacturers, or Samsung into unfair licensing terms. The firm's partners Miguel Rato and Marixenia Davilla led the defense alongside Norton Rose Fulbright's Caroline Thomas, Helen Fairhead, Nuala Canavan, and US partner Rich Zembek. Hausfeld, led by managing partner Nicola Boyle, represented Which? with counsel from Monckton Chambers.

The withdrawal underscores the ongoing challenges facing the UK's developing competition class action regime, which has faced uncertainty since the Supreme Court's 2023 PACCAR ruling on the enforceability of litigation funding agreements. For funders like Augusta Ventures, the outcome represents a significant loss on what was one of the higher-profile consumer class actions in the UK market.

The Fundamental Distinction Policymakers Cannot Ignore

By Eric Schuller |

The following was contributed by Eric K. Schuller, President, The Alliance for Responsible Consumer Legal Funding (ARC).


If policymakers want to understand consumer legal funding, they should start with insurance, not lending. At first glance, insurance and consumer legal funding may appear unrelated. One protects against risk. The other provides funds to plaintiffs in pending lawsuits to help pay for their day-to-day expenses. But structurally, they share a defining characteristic: risk is assumed by the capital provider, not imposed on the consumer. That single feature separates consumer legal funding from loans and aligns it more closely with underwriting.

Public policy depends on accurate classification. When a product is mischaracterized, regulation can miss its mark. Consumer legal funding is frequently labeled a "loan," yet its mechanics contradict that description. A loan creates a guaranteed repayment obligation. Consumer legal funding does not. To regulate wisely, lawmakers must understand that distinction.

Insurance is built on underwriting risk. An insurance company evaluates probabilities. It examines health risks, property risks, liability exposure, accident frequency. It prices policies accordingly. The insurer does not lend money to the policyholder. Instead, it assumes risk in exchange for compensation. If the insured event occurs, the insurer pays. If the event does not occur, the insurer retains the premium. In either case, the insurer's business model depends on accepting uncertainty. Insurance is not debt. It is risk transfer.

Now consider consumer legal funding. A funding company evaluates a legal claim. It assesses liability, damages, collectability, procedural posture, and likely duration. It underwrites the case. Instead of collecting premiums, it provides monies to the plaintiff. Its return depends entirely on a defined event: recovery in the lawsuit. If recovery occurs, the provider receives its agreed return from the proceeds. If recovery does not occur, the provider receives nothing. The funding company has effectively underwritten litigation risk. That is not lending. That is risk assumption.

The central question in distinguishing loans from contingent capital is simple: Who bears the risk of failure? In a loan, the borrower bears the risk. Repayment is mandatory regardless of outcome. In insurance, the insurer bears the risk. Payment depends on whether a covered event occurs. In consumer legal funding, the funding company bears the risk. Repayment depends on whether the case succeeds. If a plaintiff loses their case, they owe nothing. There is no collection action, no wage garnishment, no deficiency balance. The capital provider absorbs the loss. That structure is fundamentally inconsistent with debt.

To see the contrast clearly, consider the defining characteristics of a traditional loan: an unconditional obligation to repay, repayment regardless of performance or outcome, interest accrual over time, recourse against income or assets, and credit-based underwriting. If you borrow money to open a business and the business fails, you still owe the bank. If you lose your job after taking out a personal loan, you still owe the lender. If you use a credit card and experience hardship, the balance remains. Debt survives failure. Consumer legal funding does not. If there is no recovery in the legal claim, there is no repayment obligation. That single fact removes the defining feature of a loan.

Insurance companies price risk across portfolios. Some claims will generate losses. Others will generate gains. Sustainability depends on aggregate performance. Consumer legal funding companies operate similarly. Some cases succeed. Others fail. Pricing reflects probability of recovery, expected timeline, and litigation risk. Like insurers, funding providers must absorb unsuccessful outcomes as part of their business model. If policymakers were to impose lending-style interest caps on insurance premiums, the insurance market would collapse. Premiums are not structured like loan interest because repayment is not guaranteed. Similarly, consumer legal funding cannot be evaluated as if repayment were certain. The risk of total loss is real. When regulation ignores that risk allocation, it misunderstands the economics.

Labeling consumer legal funding as a loan may appear harmless, but it has significant policy consequences. Lending regulations are built around products where repayment is guaranteed and borrowers bear default risk. Those regulations assume predictable interest accrual and enforceable repayment obligations. Consumer legal funding lacks those features. If policymakers apply lending frameworks to non-recourse, outcome-dependent arrangements, they risk imposing regulatory structures that do not fit the product, distorting pricing models built around risk of total loss, reducing availability of funding for injured consumers, and eliminating a non-recourse option that differs fundamentally from debt. Regulation should reflect economic reality, not rhetorical convenience.

For injured plaintiffs, litigation is rarely quick. Cases may take months or years to resolve. During that time, medical bills accumulate. Rent is due. Utilities must be paid. Families rely on a steady income that may no longer exist. Traditional loans require fixed repayment regardless of outcome. Insurance does not. Consumer legal funding does not. That distinction explains why some consumers choose it. They are not borrowing against wages or income. They are accessing funds tied to a potential asset — their legal claim. If that asset produces value, repayment occurs from that value. If it does not, there is no personal debt. That is not debt stacking. It is risk sharing.

The core issue is risk transfer. Debt transfers risk to the borrower. Insurance transfers risk to the insurer. Consumer legal funding transfers litigation outcome risk to the funding company. The defining feature of a loan is an unconditional promise to repay. Without that promise, the structure changes entirely. If there is no recovery and the consumer owes nothing, the essential element of debt is absent. Policy debates should begin with that structural truth.

None of this suggests that consumer legal funding should operate without oversight. Transparent contracts, disclosure requirements, and consumer protections are appropriate in any financial arrangement. But regulation must match mechanics. Insurance is regulated as insurance because it is risk underwriting. Debt is regulated as lending because repayment is guaranteed. Consumer legal funding is non-recourse and outcome-dependent. It should be evaluated through that lens. When lawmakers start from the wrong definition, unintended consequences follow.

Consumer legal funding is non-recourse, payable only from legal proceeds, transfers outcome risk to the capital provider, and creates no unconditional repayment obligation. It shares structural similarities with insurance underwriting and other contingent compensation arrangements where payment depends on performance. The defining feature of a loan is guaranteed repayment. Consumer legal funding has no such guarantee. Before regulating it as debt, policymakers should ask a simple question: If the case fails and the consumer owes nothing, where is the loan? Sound public policy begins with structural accuracy.

Nera Capital Secures £50M Asset Mandate

By John Freund |

Nera Capital has strengthened its litigation finance platform with the onboarding of a new South America-based funding partner committing £50 million across litigation finance and legal assets. The mandate not only expands Nera’s available capital base but also sees the firm formally appointed as asset manager for the new funds, reinforcing its growing role as both originator and portfolio steward within the UK litigation market.

In a press release, Nera Capital announced that the £50 million commitment will be deployed across a range of UK-based claims, with the firm responsible for underwriting, structuring, capital deployment, and ongoing portfolio management. The capital will be allocated in line with Nera’s established investment criteria and risk management framework, targeting carefully selected legal assets. The funding partner, described as having an “extensive track record” in high-yielding special situations investments uncorrelated to traditional asset classes, brings prior experience in litigation finance across South America.

Robin Grant, CFO at Nera Capital, emphasized that the partnership aligns with the firm’s disciplined approach to litigation finance and enhances its ability to deliver attractive, risk-adjusted returns to investors. Aisling Byrne, Director at Nera Capital, highlighted the funder’s blend of financial and legal expertise, noting that the asset manager appointment reflects international confidence in Nera’s ability to identify viable claims and manage them through to resolution.

Established in 2011 and headquartered in Dublin, with offices in Manchester and Holland, Nera Capital provides law firm lending across consumer and commercial claim portfolios and is a member of the European Litigation Funders Association.

Fundraising

View All

Case Developments

View All

Legal Innovation

View All

People Moves

View All

Regulatory

View All

Consumer

View All

Thought Leadership

View All